BACKGROUND: Normothermic machine perfusion of the liver (NMP-L) is a novel technique that preserves liver grafts under near-physiological conditions while maintaining their normal metabolic activity. This process requires an adequate oxygen supply, typically delivered by packed red blood cells (RBC). We present the first experience using an acellular hemoglobin-based oxygen carrier (HBOC) Hemopure in a human model of NMP-L. METHODS: Five discarded high-risk human livers were perfused with HBOC-based perfusion fluid and matched to 5 RBC-perfused livers. Perfusion parameters, oxygen extraction, metabolic activity, and histological features were compared during 6 hours of NMP-L. The cytotoxicity of Hemopure was also tested on human hepatic primary cell line cultures using an in vitro model of ischemia reperfusion injury. RESULTS: The vascular flow parameters and the perfusate lactate clearance were similar in both groups. The HBOC-perfused livers extracted more oxygen than those perfused with RBCs (O2 extraction ratio 13.75 vs 9.43 % ×10 per gram of tissue, P = 0.001). In vitro exposure to Hemopure did not alter intracellular levels of reactive oxygen species, and there was no increase in apoptosis or necrosis observed in any of the tested cell lines. Histological findings were comparable between groups. There was no evidence of histological damage caused by Hemopure. CONCLUSIONS: Hemopure can be used as an alternative oxygen carrier to packed red cells in NMP-L perfusion fluid.
BACKGROUND: Normothermic machine perfusion of the liver (NMP-L) is a novel technique that preserves liver grafts under near-physiological conditions while maintaining their normal metabolic activity. This process requires an adequate oxygen supply, typically delivered by packed red blood cells (RBC). We present the first experience using an acellular hemoglobin-based oxygen carrier (HBOC) Hemopure in a human model of NMP-L. METHODS: Five discarded high-risk human livers were perfused with HBOC-based perfusion fluid and matched to 5 RBC-perfused livers. Perfusion parameters, oxygen extraction, metabolic activity, and histological features were compared during 6 hours of NMP-L. The cytotoxicity of Hemopure was also tested on human hepatic primary cell line cultures using an in vitro model of ischemia reperfusion injury. RESULTS: The vascular flow parameters and the perfusate lactate clearance were similar in both groups. The HBOC-perfused livers extracted more oxygen than those perfused with RBCs (O2 extraction ratio 13.75 vs 9.43 % ×10 per gram of tissue, P = 0.001). In vitro exposure to Hemopure did not alter intracellular levels of reactive oxygen species, and there was no increase in apoptosis or necrosis observed in any of the tested cell lines. Histological findings were comparable between groups. There was no evidence of histological damage caused by Hemopure. CONCLUSIONS: Hemopure can be used as an alternative oxygen carrier to packed red cells in NMP-L perfusion fluid.
Authors: J Pirenne; F Van Gelder; W Coosemans; R Aerts; B Gunson; T Koshiba; I Fourneau; D Mirza; W Van Steenbergen; J Fevery; F Nevens; P McMaster Journal: Liver Transpl Date: 2001-06 Impact factor: 5.799
Authors: Aryeh Shander; Axel Hofmann; Sherri Ozawa; Oliver M Theusinger; Hans Gombotz; Donat R Spahn Journal: Transfusion Date: 2009-12-09 Impact factor: 3.157
Authors: Juraj Sprung; James D Kindscher; Joyce A Wahr; Jerrold H Levy; Terri G Monk; Mark W Moritz; Patrick J O'Hara Journal: Anesth Analg Date: 2002-04 Impact factor: 5.108
Authors: Philipp Dutkowski; Wojciech G Polak; Paolo Muiesan; Andrea Schlegel; Cornelia J Verhoeven; Irene Scalera; Michelle L DeOliveira; Philipp Kron; Pierre-Alain Clavien Journal: Ann Surg Date: 2015-11 Impact factor: 12.969
Authors: Ricky H Bhogal; Christopher J Weston; Stuart M Curbishley; David H Adams; Simon C Afford Journal: PLoS One Date: 2012-01-25 Impact factor: 3.240
Authors: Sayf A Said; Carlos X Ordeñana; Majid Rezaei; Brian A Figueroa; Srinivasan Dasarathy; Henri Brunengraber; Antonio Rampazzo; Bahar Bassiri Gharb Journal: Mil Med Date: 2020-01-07 Impact factor: 1.437
Authors: Laura C Burlage; Alexandre G Lellouch; Corentin B Taveau; Philipp Tratnig-Frankl; Casie A Pendexter; Mark A Randolph; Robert J Porte; Laurent A Lantieri; Shannon N Tessier; Curtis L Cetrulo; Korkut Uygun Journal: J Surg Res Date: 2021-10-17 Impact factor: 2.192
Authors: Heather Jennings; Kristin N Carlson; Chris Little; Joshua C Verhagen; Jeevan Nagendran; Yongjun Liu; Bret Verhoven; Weifeng Zeng; Stacey McMorrow; Peter Chlebeck; David P Al-Adra Journal: Front Immunol Date: 2022-06-22 Impact factor: 8.786
Authors: Alix P M Matton; Laura C Burlage; Rianne van Rijn; Yvonne de Vries; Shanice A Karangwa; Maarten W Nijsten; Annette S H Gouw; Janneke Wiersema-Buist; Jelle Adelmeijer; Andrie C Westerkamp; Ton Lisman; Robert J Porte Journal: Liver Transpl Date: 2018-04 Impact factor: 5.799